Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance

This publication has 43 references indexed in Scilit:

• In vitro activity of 2-chlorodeoxyadenosine (CdA) in primary cultures of human haematological and solid tumours
  European Journal Of Cancer, 1994
• Use of the Kohonen Self-organizing Map to Study the Mechanisms of Action of Chemotherapeutic Agents
  JNCI Journal of the National Cancer Institute, 1994
• Detection of tumor‐specific cytotoxic drug activity IN VITRO using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients
  International Journal of Cancer, 1994
• Predictive statistics and artificial intelligence in the U.S. National Cancer Institute's drug discovery program for cancer and AIDS
  The International Journal of Cell Cloning, 1994
• Antineoplastic Drug Screening Belongs in the Laboratory, Not in the Clinic
  JNCI Journal of the National Cancer Institute, 1992
• Multidrug resistance from the clinical point of view
  European Journal of Cancer and Clinical Oncology, 1991
• Pharmacological modification of multi‐drug resistance (mdr) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin a and verapamil on mdr leukemia t‐cells
  International Journal of Cancer, 1990
• Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm
  JNCI Journal of the National Cancer Institute, 1989
• Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26
  Biochemistry, 1988
• Current results of the screening program at the division of cancer treatment, national cancer institute
  Published by Elsevier ,1981